$HNGE

Insight Holdings Group, LLC sold $4.6M of HNGE (indirect holdings)

Insight Holdings Group, LLC sold 65,581 indirectly-held shares of Hinge Health, Inc. (HNGE) at $70.36 ($4.61M total) across 4 trades on 2026-06-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Insight Holdings Group, LLC
Published Jun 19, 2026, 1:52 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 19, 2026, 2:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The disclosed sale provides a fresh datapoint on insider behavior and can influence short-term sentiment, but it does not change fundamentals or guidance.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 framing suggests limited incremental information about near-term performance.

03

What to watch

The article does not disclose total compensation, tax-motivated selling, or whether other insiders/funds are buying; without those, the signal is incomplete.

Relevance 5/10Novelty 5/10Timing: after-hours/filing update (Form 4 filed 2026-06-18 for 2026-06-16 trades)

Background

The filing is a SEC Form 4 insider transaction: Insight Holdings Group, LLC (10% owner) sold Hinge Health shares indirectly under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health disclosed an open-market sale by a 10% owner via a Rule 10b5-1 plan: 65,581 shares sold at $70.3596 on 2026-06-16.

Expected impact

Likely limited near-term price impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

Form 4 provides a concrete transaction size and price, yet it is explicitly under a pre-arranged 10b5-1 plan and does not indicate new operating or regulatory developments.

Market effects

No sector read-through; this is a single-company insider transaction with no stated business change.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan and the filing shows zero shares remaining, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    Subject of the Form 4 insider transaction; 65,581 shares sold at $70.3596 by a 10% owner via 10b5-1.

  • Insight Holdings Group, LLC

    10% owner reporting an open-market sale of HNGE shares; holdings after transaction: 0 shares.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.